Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company UGP-Therapeutics Inc.
DescriptionAnorexigenic peptide targeting the amylin receptor
Molecular Target Amylin receptor
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationObesity
Indication DetailsTreat obesity
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today